The EU Council Working Party on Pharmaceuticals and Medical devices discussed, on Tuesday 17 May, a first draft compromise on serious cross-border threats to health.
This draft, of which EUROPE obtained a copy, differs relatively little from the proposal for a regulation on the subject drawn up by the European Commission.
Of the few changes, however, some are intended to give Member States greater flexibility in relation to EU-imposed protocols, including protocols for assessing their...